SCHEMBL6407683

SCHEMBL6407683

COC(=O)C1C(COCc2ccc(OC)cc2)C1(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP3 P08254 1/20 0.44
MMP9 P14780 1/20 0.44
MMP13 P45452 1/20 0.44
HTT P42858 2/20 0.44
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
POLB P06746 1/20 0.40
F2RL1 P55085 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
FABP7 O15540 1/20 0.39
FABP5 Q01469 1/20 0.39
FFAR1 O14842 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408318 0.88 ALDH1A1 (0.42) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6406010 0.88 MMP1 (0.45) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6408893 0.87 L3MBTL1 (0.41) MMP1MMP2MMP3MMP9MMP13
SCHEMBL3362063 0.86 MMP1 (0.43) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6406894 0.84 CACNA1B (0.43) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6406988 0.84 NAAA (0.40) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6412497 0.81 KMT2A (0.43) HTTALDH1A1POLBCA2
SCHEMBL6407225 0.79 MMP1 (0.37) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6532218 0.77 ALDH1A1 (0.40) ALDH1A1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL6473488 0.77 CYP19A1 (0.45) HTTALDH1A1MAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 MMP1 3579/4885MMP2 2857/4885MMP3 2989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.